Pulmovant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026
2026-09-06 01:00 ET - News Release
© 2026 Canjex Publishing Ltd. All rights reserved.